Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe RheumatoId Arthritis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03254966
What this trial is testing

Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients

Who this might be right for
Rheumatoid Arthritis
Jiangsu HengRui Medicine Co., Ltd. 194
Testing effectiveness (Phase 2)Study completedNCT02309359
What this trial is testing

A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Ablynx, a Sanofi company 345
Post-approval studies (Phase 4)UnknownNCT02087696
What this trial is testing

Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Spanish Foundation of Rheumatology 122
Testing effectiveness (Phase 2)Study completedNCT02379091
What this trial is testing

Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Takeda 108
Post-approval studies (Phase 4)Study completedNCT01034397
What this trial is testing

Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 54
Large-scale testing (Phase 3)Study completedNCT02167139
What this trial is testing

A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Who this might be right for
Rheumatoid Arthritis
Samsung Bioepis Co., Ltd. 544
Testing effectiveness (Phase 2)Study completedNCT06565273
What this trial is testing

Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd 40
Not applicableUnknownNCT03106259
What this trial is testing

Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj

Who this might be right for
Rheumatoid Arthritis
Kang Stem Biotech Co., Ltd. 9
Very early researchNot Yet RecruitingNCT06982547
What this trial is testing

Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection

Who this might be right for
Rheumatoid Arthritis (RA)
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT02722044
What this trial is testing

Usability of an AI for M923 in Subjects With Moderate to Severe RA

Who this might be right for
Rheumatoid Arthritis
Momenta Pharmaceuticals, Inc. 33
Not applicableStudy completedNCT01362062
What this trial is testing

Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 110
Early research (Phase 1)Study completedNCT01955603
What this trial is testing

A Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0215-0384 Administered to Subjects With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
InflammationRheumatoid Arthritis
Novo Nordisk A/S 24
Testing effectiveness (Phase 2)Ended earlyNCT02882087
What this trial is testing

The Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis

Who this might be right for
Moderate and Severe Rheumatoid Arthritis
RemeGen Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00887341
What this trial is testing

A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 76
Testing effectiveness (Phase 2)Study completedNCT01468077
What this trial is testing

A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 47
Large-scale testing (Phase 3)Ended earlyNCT01198002
What this trial is testing

A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 1,041
Large-scale testing (Phase 3)Study completedNCT02706951
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)

Who this might be right for
Rheumatoid Arthritis
AbbVie 648
Large-scale testing (Phase 3)Study completedNCT06104124
What this trial is testing

Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Who this might be right for
Sjogren's Syndrome
Amgen 651
Post-approval studies (Phase 4)Study completedNCT01185288
What this trial is testing

Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)

Who this might be right for
Rheumatoid Arthritis
AbbVie (prior sponsor, Abbott) 309
Large-scale testing (Phase 3)Study completedNCT00848120
What this trial is testing

Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 29
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation